TRCT
DRTX

Tower Research Capital (TRC)’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,576
Closed -$20K – 5444
2014
Q3 		$20K Buy
+1,576
New +$23.5K ﹤0.01% 2321
2014
Q2 		– Sell
-3,432
Closed -$46K – 5262
2014
Q1 		$46K Buy
3,432
+456
+15% +$5.97K 0.01% 1159
2013
Q4 		$38K Sell
2,976
-1,918
-39% -$20.1K 0.01% 1645
2013
Q3 		$44K Buy
4,894
+4,794
+4,794% +$39.8K ﹤0.01% 2035
2013
Q2 		$1K Buy
+100
New +$734 ﹤0.01% 3841

Tower Research Capital (TRC)'s DRTX Position: Q4 2014 in Review

Tower Research Capital (TRC) sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 1,576 shares — an estimated $20K sold.

Tower Research Capital (TRC) first reported a position in DRTX in Q2 2013 and held it in 5 quarters. The position peaked at $46K in Q1 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • Tower Research Capital (TRC) reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,576 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $20K.
  • Tower Research Capital (TRC) first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s DURATA THERAPEUTICS INC COM STK (DE) position peaked at $46K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2014, filed 5 Feb 2015.